Examiner training: A study of examiners making sense of norm-referenced feedbackMEDICAL TEACHERIF4.42019-03-265OAAI
Structural brain abnormalities and altered sensitivity to psychotomimetic drugs in neuregulin-1 knockout miceEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72009-09-010PREAI
The role of human demographic history in determining the distribution and frequency of transferase-deficient galactosaemia mutationsHEREDITYIF3.92009-07-2917OAAI
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' micePROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92009-03-018PREAI
Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92008-02-0180OAAI
An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy and other complex diseasesEUROPEAN JOURNAL OF HUMAN GENETICSIF4.62007-10-315OAAI
Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviourNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92007-01-01134PREAI
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72006-08-0114OAAI
The leukocyte protein L-plastin induces proliferation, invasion and loss of E-cadherin expression in colon cancer cellsINTERNATIONAL JOURNAL OF CANCERIF4.72005-11-1476OAAI
Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interfacePSYCHOPHARMACOLOGYIF3.32005-07-2281PREAI
Genetic stratification of pathogen-response-related and other variants within a homogeneous Caucasian Irish populationEUROPEAN JOURNAL OF HUMAN GENETICSIF4.62005-03-2312OAAI
Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3′, 5′-monophosphate-regulated phosphoprotein of 32 kDa knockout mutants congenic on the C57BL/6 genetic backgroundJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82004-09-0113PREAI
Frequency distribution of the Los Angeles and Duarte galactose-1-phosphate uridyltransferase variant alleles in the Irish populationMOLECULAR GENETICS AND METABOLISMIF3.52004-08-015PREAI
Identification of sequence variation in the galactose-1-phosphate uridyl transferase gene by dHPLCMOLECULAR GENETICS AND METABOLISMIF3.52004-02-016PREAI
Topographical evaluation of spontaneous and agonist-induced behaviour in mutants with congenic dopamine D4 versus D5 receptor knockoutEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72004-01-012PREAI
Topographical assessment of ethological and dopamine receptor agonist-induced behavioral phenotype in mutants with congenic DARPP-32 'knockout'NEUROPSYCHOPHARMACOLOGYIF7.12003-06-0525OAAI
Genetic diversity within the R408W phenylketonuria mutation lineages in EuropeHUMAN MUTATIONIF3.72003-03-1931PREAI
Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization (vol 21, pg 3253, 2002)ONCOGENEIF7.32002-11-061OAAI
The mutation spectrum of hyperphenylalaninaemia in the Republic of Ireland: the population history of the Irish revisitedEUROPEAN JOURNAL OF HUMAN GENETICSIF4.62002-08-1323OAAI
Congenic D1A dopamine receptor mutants:: Ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotypeNEUROPSYCHOPHARMACOLOGYIF7.12002-06-1452OAAI